Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Treprostinil

A stable prostacyclin analogue that widens the lung's blood vessels and curbs platelet aggregation: approved in the United States in 2002, it is used in pulmonary arterial hypertension by subcutaneous, intravenous, inhaled or oral route. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?Epoprostenol, the prostacyclin used as a medicine, stays active in the blood for only a few minutes; treprostinil, stable at room temperature, lasts a few hours and can be infused under the skin with a small pump.

TreprostinilGo to the active ingredient →
TreprostinilActive ingredientTreprostinilCat. No. P-T186-001CAS 81846-19-7

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.